Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
67.05
+0.02 (0.03%)
Apr 24, 2024, 12:26 PM EDT - Market open
Gilead Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 6,085 | 5,412 | 5,338 | 5,997 | 11,631 | 17,940 | 7,588 | 8,229 | 12,851 | 10,027 | Upgrade
|
Short-Term Investments | 1,179 | 973 | 1,182 | 1,411 | 12,721 | 12,149 | 17,922 | 3,666 | 1,756 | 101 | Upgrade
|
Cash & Cash Equivalents | 7,264 | 6,385 | 6,520 | 7,408 | 24,352 | 30,089 | 25,510 | 11,895 | 14,607 | 10,128 | Upgrade
|
Cash Growth | 13.77% | -2.07% | -11.99% | -69.58% | -19.07% | 17.95% | 114.46% | -18.57% | 44.22% | 375.05% | Upgrade
|
Receivables | 4,660 | 4,777 | 4,493 | 4,892 | 3,582 | 3,327 | 3,851 | 4,514 | 5,854 | 4,635 | Upgrade
|
Inventory | 1,787 | 1,507 | 1,618 | 1,683 | 922 | 814 | 801 | 1,587 | 1,955 | 1,386 | Upgrade
|
Other Current Assets | 2,374 | 1,774 | 2,141 | 2,013 | 1,440 | 1,606 | 1,661 | 1,592 | 2,346 | 1,565 | Upgrade
|
Total Current Assets | 16,085 | 14,443 | 14,772 | 15,996 | 30,296 | 35,836 | 31,823 | 19,588 | 24,762 | 17,714 | Upgrade
|
Property, Plant & Equipment | 5,317 | 5,475 | 5,121 | 4,967 | 4,502 | 4,006 | 3,295 | 2,865 | 2,276 | 1,674 | Upgrade
|
Long-Term Investments | 1,163 | 1,245 | 1,309 | 502 | 1,488 | 1,423 | 11,184 | 20,485 | 11,601 | 1,598 | Upgrade
|
Goodwill and Intangibles | 34,768 | 37,208 | 41,787 | 41,234 | 17,903 | 19,855 | 21,259 | 10,143 | 11,419 | 12,245 | Upgrade
|
Other Long-Term Assets | 4,792 | 4,800 | 4,963 | 5,708 | 7,438 | 2,555 | 2,722 | 3,896 | 1,658 | 1,433 | Upgrade
|
Total Long-Term Assets | 46,040 | 48,728 | 53,180 | 52,411 | 31,331 | 27,839 | 38,460 | 37,389 | 26,954 | 16,950 | Upgrade
|
Total Assets | 62,125 | 63,171 | 67,952 | 68,407 | 61,627 | 63,675 | 70,283 | 56,977 | 51,716 | 34,664 | Upgrade
|
Accounts Payable | 550 | 905 | 705 | 844 | 713 | 790 | 814 | 1,206 | 1,178 | 955 | Upgrade
|
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 440 | 134 | Upgrade
|
Current Debt | 1,798 | 2,273 | 1,516 | 2,757 | 2,499 | 2,748 | 2,747 | 0 | 982 | 483 | Upgrade
|
Other Current Liabilities | 8,932 | 8,059 | 9,389 | 7,796 | 6,547 | 7,067 | 8,074 | 8,012 | 7,290 | 4,189 | Upgrade
|
Total Current Liabilities | 11,280 | 11,237 | 11,610 | 11,397 | 9,759 | 10,605 | 11,635 | 9,218 | 9,890 | 5,761 | Upgrade
|
Long-Term Debt | 23,189 | 22,957 | 25,179 | 28,645 | 22,094 | 24,574 | 30,795 | 26,346 | 21,073 | 11,921 | Upgrade
|
Other Long-Term Liabilities | 4,907 | 7,768 | 10,099 | 10,144 | 7,124 | 6,962 | 7,352 | 2,050 | 1,640 | 1,163 | Upgrade
|
Total Long-Term Liabilities | 28,096 | 30,725 | 35,278 | 38,789 | 29,218 | 31,536 | 38,147 | 28,396 | 22,713 | 13,084 | Upgrade
|
Total Liabilities | 39,376 | 41,962 | 46,888 | 50,186 | 38,977 | 42,141 | 49,782 | 37,614 | 32,603 | 18,845 | Upgrade
|
Total Debt | 24,987 | 25,230 | 26,695 | 31,402 | 24,593 | 27,322 | 33,542 | 26,346 | 22,055 | 12,404 | Upgrade
|
Debt Growth | -0.96% | -5.49% | -14.99% | 27.69% | -9.99% | -18.54% | 27.31% | 19.46% | 77.81% | 86.92% | Upgrade
|
Retained Earnings | 16,304 | 15,687 | 16,324 | 14,381 | 19,388 | 19,024 | 19,012 | 18,154 | 18,001 | 12,732 | Upgrade
|
Comprehensive Income | 28 | 2 | 83 | -60 | 85 | 80 | 165 | 278 | 88 | 301 | Upgrade
|
Shareholders' Equity | 22,833 | 21,240 | 21,069 | 18,202 | 22,525 | 21,387 | 20,442 | 18,887 | 18,534 | 15,426 | Upgrade
|
Net Cash / Debt | -17,723 | -18,845 | -20,175 | -23,994 | -241 | 2,767 | -8,032 | -14,451 | -7,448 | -2,276 | Upgrade
|
Net Cash Per Share | -14.09 | -14.93 | -15.99 | -19.00 | -0.19 | 2.12 | -6.09 | -10.64 | -4.90 | -1.38 | Upgrade
|
Working Capital | 4,805 | 3,206 | 3,162 | 4,599 | 20,537 | 25,231 | 20,188 | 10,370 | 14,872 | 11,953 | Upgrade
|
Book Value Per Share | 18.30 | 16.92 | 16.77 | 14.48 | 17.74 | 16.48 | 15.64 | 14.11 | 12.66 | 10.13 | Upgrade
|